| Page Range | 34875-34876 | |
| FR Document | 2018-15721 |
[Federal Register Volume 83, Number 141 (Monday, July 23, 2018)] [Notices] [Pages 34875-34876] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-15721] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: VHG Labs DBA LGC Standards ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 22, 2018. Such persons may also file a written request for a hearing on the application on or before August 22, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 13, 2018, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchaster NH 03103 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3- 1233 I FMC). Cathinone....................... 1235 I Methcathinone................... 1237 I 4-Fluoro-N-methylcathinone (4- 1238 I FMC). Pentedrone ([alpha]- 1246 I methylaminovalerophenone). Mephedrone (4-Methyl-N- 1248 I methylcathinone). 4-Methyl-N-ethylcathinone (4- 1249 I MEC). Naphyrone....................... 1258 I N-Ethylamphetamine.............. 1475 I 4-Methylaminorex (cis isomer)... 1590 I Methaqualone.................... 2565 I JWH-250 (1-Pentyl-3-(2- 6250 I methoxyphenylacetyl) indole). SR-18 (Also known as RCS-8) (1- 7008 I Cyclohexylethyl-3-(2- methoxyphenylacetyl) indole). APINACA and AKB48 N-(1- 7048 I Adamantyl)-1-pentyl-1H-indazole- 3-carboxamide. JWH-081 (1-Pentyl-3-(1-(4- 7081 I methoxynaphthoyl) indole). SR-19 (Also known as RCS-4) (1- 7104 I Pentyl-3-[(4-methoxy)-benzoyl] indole. JWH-018 (also known as AM678) (1- 7118 I Pentyl-3-(1-naphthoyl)indole). JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I naphthoyl) indole). UR-144 (1-Pentyl-1H-indol-3- 7144 I yl)(2,2,3,3- tetramethylcyclopropyl)methanon e. AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I naphthoyl) indole). JWH-203 (1-Pentyl-3-(2- 7203 I chlorophenylacetyl) indole). Ibogaine........................ 7260 I Lysergic acid diethylamide...... 7315 I 2,5-Dimethoxy-4-(n)- 7348 I propylthiophenethylamine (2C-T- 7). Marihuana....................... 7360 I Mescaline....................... 7381 I 2-(4-Ethylthio-2,5- 7385 I dimethoxyphenyl) ethanamine (2C- T-2 ). [[Page 34876]] 4-Bromo-2,5-dimethoxyamphetamine 7391 I 4-Bromo-2,5- 7392 I dimethoxyphenethylamine. JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I naphthoyl) indole). 3,4-Methylenedioxyamphetamine... 7400 I N-Hydroxy-3,4- 7402 I methylenedioxyamphetamine. 3,4-Methylenedioxy-N- 7404 I ethylamphetamine. 3,4- 7405 I Methylenedioxymethamphetamine. 4-Methoxyamphetamine............ 7411 I 5-Methoxy-N-N-dimethyltryptamine 7431 I Alpha-methyltryptamine.......... 7432 I Bufotenine...................... 7433 I Dimethyltryptamine.............. 7435 I Psilocyn........................ 7438 I N-Benzylpiperazine.............. 7493 I 4-Methyl- 7498 I alphapyrrolidinopropiophenone (4-MePPP). 2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I ethanamine (2C-E ). 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I ethanamine (2C-I). 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I ethanamine (2C-C). MDPV (3,4- 7535 I Methylenedioxypyrovalerone). 2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I N-(2-methoxybenzyl) ethanamine (25C-NBOMe). Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Butylone........................ 7541 I Pentylone....................... 7542 I alpha-pyrrolidinopentiophenone 7545 I ([alpha]-PVP). AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I iodobenzoyl) indole). Codeine-N-oxide................. 9053 I Desomorphine.................... 9055 I Dihydromorphine................. 9145 I Heroin.......................... 9200 I Morphine-N-oxide................ 9307 I Normorphine..................... 9313 I Pholcodine...................... 9314 I Dipipanone...................... 9622 I Properidine..................... 9644 I Tilidine........................ 9750 I Alpha-methylfentanyl............ 9814 I Methamphetamine................. 1105 II Phenmetrazine................... 1631 II Amobarbital..................... 2125 II Pentobarbital................... 2270 II Secobarbital.................... 2315 II Glutethimide.................... 2550 II Phencyclidine................... 7471 II Phenylacetone................... 8501 II Alphaprodine.................... 9010 II Dihydrocodeine.................. 9120 II Diphenoxylate................... 9170 II Ecgonine........................ 9180 II Ethylmorphine................... 9190 II Levorphanol..................... 9220 II Isomethadone.................... 9226 II Meperidine...................... 9230 II Meperidine intermediate-B....... 9233 II Meperidine intermediate-C....... 9234 II Dextropropoxyphene, bulk (non- 9273 II dosage forms). 14-Hydroxmorphone............... 9665 II Noroxymorphone.................. 9668 II Remifentanil.................... 9739 II Sufentanil...................... 9740 II ------------------------------------------------------------------------ The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substance. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a) (2). Authorization will not extend to the import of FDA approved or non- approved finished dosage forms for commercial sale. Dated: July 12, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-15721 Filed 7-20-18; 8:45 am] BILLING CODE 4410-09-P
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 22, 2018. Such persons may also file a written request for a hearing on the application on or before August 22, 2018. | |
| FR Citation | 83 FR 34875 |